Latest Science Press Releases

BOSTON, MA. 23rd August, 2024 - eLabNext, an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic La...

BOSTON, MA. August 9th, 2024 – eLabNext, an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic L...

Mr. Headley, Ph.D. at Stanford, joins Wonderfeel’s Scientific Advisory Board, and Mr. Cifuentes MD, a clinical pharmacologist is promoted to the Director of R&D position. SAN FRANCISCO, CA, ...

NOTTINGHAM, UK. July 16th, 2024 - Upperton Pharma Solutions, a contract development and manufacturing organisation (CDMO), is pleased to announce the successful completion of a Medicines and Healt...

BOSTON, MA, USA. May 13th, 2024 – eLabNext, an Eppendorf Group Company and leading provider of Digital Lab Platforms that include lab inventory management systems (LIMS), electronic lab notebook...

THE PARANORMAL UFO CONNECTION - A NEW MOVIE OUT NOW ON TUBILONDON, UK, 29 March 2024 – A new documentary now streaming in Tubi explores the paranormal aspect of UFOs. Nick Pope who used to head ...

UTAH, UNITED STATES, 8 March 2024 – With anticipation building for the total solar eclipse on April 8th, 2024, Eclipse Glasses USA is committed to ensuring that eclipse watchers experience this ...

CORK, IRELAND, March 05, 2024 - Applied Biopharm Consulting Ltd has been awarded a grant from the Local Enterprise Office Cork North and West to fund a feasibility study, as part of an office-base...

London, UK, November 4th, 2022 – Esya Labs, a startup dedicated to developing early-stage biomarkers for neurodegenerative diseases, has been awarded a grant of $452,000 from The Michael J. Fox F...

LONDON, UK, 9th May 2023 - Zero announced it is opening its first synthetic fuel facility (“Plant Zero.1”) on 14th June 2023. The facility will include the world’s first fully-featured synthe...

Greenbackers Investment Capital has revealed the identity of 26 climate technology start-ups who will be taking part in an innovative six-month programme designed to help them secure international...

CAMBRIDGE UK – Excivion Ltd (www.excivion.com), a biotechnology company developing novel vaccines based on its proprietary glycan-cloaking molecular design and adjuvant platforms, today announce...